comparemela.com

Latest Breaking News On - National technical advisory - Page 4 : comparemela.com

India may soon start in few weeks testing feasibility of a regimen that mixes 2 different doses of Covid vaccines - दो अलग-अलग कोरोना टीके की डोज लगवाने पर क्या होगा असर? स्टडी कराएगी सरकार

India may soon start in few weeks testing feasibility of a regimen that mixes 2 different doses of Covid vaccines - दो अलग-अलग कोरोना टीके की डोज लगवाने पर क्या होगा असर? स्टडी कराएगी सरकार
livehindustan.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from livehindustan.com Daily Mail and Mail on Sunday newspapers.

Extending gap between two doses of Covishield not to spare vaccines, clarifies Dr NK Arora

Gap between Covishield doses extended based on real-life data, not to spare jabs: Dr NK Arora | Exclusive Sneha Mordani Chairman of India s Technical Advisory Group on Covid-19 vaccination, Dr NK Arora, has defended the Centre s decision to increase the gap between both doses of Covishield to 12-16 weeks from the earlier norm of 6-8 weeks. The Health Ministry accepted the recommendation on Thursday. It was the National Technical Advisory Group on immunisation headed by Dr Arora that had recommended extending the gap between two doses of the Covid-19 vaccine. Covishield, developed by the University of Oxford and AstraZeneca, is being produced by Pune-based Serum Institute of India (SII).

Gap between Covishield doses extended based on real-life data, not to spare jabs: Dr NK Arora

Gap between Covishield doses extended based on real-life data, not to spare jabs: Dr NK Arora | Exclusive Sneha Mordani Chairman of India s Technical Advisory Group on Covid-19 vaccination, Dr NK Arora, has defended the Centre s decision to increase the gap between both doses of Covishield to 12-16 weeks from the earlier norm of 6-8 weeks. The Health Ministry accepted the recommendation on Thursday. It was the National Technical Advisory Group on immunisation headed by Dr Arora that had recommended extending the gap between two doses of the Covid-19 vaccine. Covishield, developed by the University of Oxford and AstraZeneca, is being produced by Pune-based Serum Institute of India (SII).

Gap between Covishield doses extended based on real-life data, not to spare jabs: Dr NK Arora | Exclusive

Gap between Covishield doses extended based on real-life data, not to spare jabs: Dr NK Arora | Exclusive Dr NK Arora, Chairman of India s Technical Advisory Group on Covid-19 vaccination, addressed key concerns about the recommendation to extend the gap between two doses of Covishield and whether the Covid-19 vaccine is safe for lactating women. advertisement UPDATED: May 15, 2021 00:38 IST A medic prepares to administer a dose of Covid-19 vaccine Covishield at a vaccination centre in Delhi on May 3, 2021 (Photo Credits: PTI) HIGHLIGHTS Lactating women are eligible for getting the Covid-19 vaccines: Dr NK Arora Setting up platform to monitor breakthrough infections, will review decision after 3-4 months: Dr NK Arora

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.